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Chronic neuroinflammation, which is primarily mediated by microglia, plays an essential
role in aging and neurodegeneration. It is still unclear whether this microglia-induced
neuroinflammation occurs globally or is confined to distinct brain regions. In this
study, we investigated microglia activity in various brain regions upon healthy aging
and Alzheimer’s disease (AD)-related pathology in both human and mouse samples.
In purified microglia isolated from aging mouse brains, we found a profound gene
expression pattern related to pro-inflammatory processes, phagocytosis, and lipid
homeostasis. Particularly in white matter microglia of 24-month-old mice, abundant
expression of phagocytic markers including Mac-2, Axl, CD16/32, Dectin1, CD11c, and
CD36 was detected. Interestingly, in white matter of human brain tissue the first signs
of inflammatory activity were already detected during middle age. Thus quantification of
microglial proteins, such as CD68 (commonly associated with phagocytosis) and HLA-
DR (associated with antigen presentation), in postmortem human white matter brain
tissue showed an age-dependent increase in immunoreactivity already in middle-aged
people (53.2 ± 2.0 years). This early inflammation was also detectable by non-invasive
positron emission tomography imaging using [11C]-(R)-PK11195, a ligand that binds
to activated microglia. Increased microglia activity was also prominently present in the
white matter of human postmortem early-onset AD (EOAD) brain tissue. Interestingly,
microglia activity in the white matter of late-onset AD (LOAD) CNS was similar to
that of the aged clinically silent AD cases. These data indicate that microglia-induced
neuroinflammation is predominant in the white matter of aging mice and humans as well
as in EOAD brains. This white matter inflammation may contribute to the progression of
neurodegeneration, and have prognostic value for detecting the onset and progression
of aging and neurodegeneration.
Keywords: white matter, microglia, neuroinflammation, aging, Alzheimer’s disease
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INTRODUCTION
Chronic neuroinflammation is a long-lasting inflammatory
response that includes the persistent activation of local immune
cells (microglia), the release of inflammatory molecules, and
the enhancement of oxidative stress (Frank-Cannon et al.,
2009). Gene expression studies in the aging brain have clearly
outlined the importance of neuroinflammation and its role in
neurodegenerative diseases (Lee et al., 2000; Lu et al., 2004;
Glorioso and Sibille, 2011). Glia cells, particularly microglia, are
the major source of expressed neuroinflammatory genes in the
brain of aged mice. The expression of molecules involved in
pattern recognition (Letiembre et al., 2007) and phagocytosis
(Hickman et al., 2013) is increased in aged microglia. Aging
microglia respond stronger to peripheral immune stimuli,
alluded to as microglia priming (Perry et al., 2007; Sierra et al.,
2007; Godbout et al., 2008; Raj et al., 2014).
Age is the primary risk factor for neurodegenerative
diseases (e.g., AD and Parkinson’s disease) (Hung et al.,
2010). Accumulating evidence suggests that microglia-induced
neuroinflammation is a major contributor to the etiology of age-
related neurodegeneration (Krstic and Knuesel, 2013; Heppner
et al., 2015), rather than a passive response. The process of
neurodegeneration is associated with chronic neuroinflammation
in various neurodegenerative diseases (Frank-Cannon et al.,
2009). However, our understanding of neuroinflammation is still
limited with respect to its causes and progression. Detecting
neuroinflammation at an early stage may become a key for
finding the means of preclinical diagnosis and therapeutic
interventions (Yankner, 2000).
Microglia display phenotypical diversity in different brain
regions (Olah et al., 2011), and brain region-specific effects of
aging on microglial gene expression have also been reported
(Grabert et al., 2016). With increasing age, the number of
HLA-DR/MHC II-positive microglia, particularly in the white
matter, is increased compared to other brain regions (Ogura
et al., 1994; Sheffield and Berman, 1998). This may influence
the myelin loss, and lead to the eventual cognitive decline
as observed in aged human and non-human primates (Ogura
et al., 1994; Sheffield and Berman, 1998). It has been reported
that iNOS immunoreactive microglia mediate increased protein
nitration in the white matter of the aging non-human primate
brain (Sloane et al., 1999). This might lead to a decrease
in white matter integrity. In addition, upon aging, white
matter was shown to contain complement-immunoreactive
oligodendrocytes in association with activated microglia (Duce
et al., 2006). Both CD11c-positive cells and CD3-positive T
cells were particularly enriched in the white matter of the
aged brain (Stichel and Luebbert, 2007), which indicates a
crucial role of leukocytes in age-related response in the brain.
These studies suggest that microglia-induced neuroinflammation
Abbreviations: AD, Alzheimer’s disease; BPP, binding potential; CDR, clinical
dementia rating; CNS, central nervous system; CRP, C-reactive protein;
EOAD, early-onset Alzheimer’s disease; FACS, fluorescence-activated cell sorting;
FDR, false discovery rate; GO, gene ontology; LOAD, late-onset Alzheimer’s
disease; NFT, neurofibrillary tangles; PET, positron emission tomography; PFA,
paraformaldehyde; ROIs, regions of interest; SPM, Statistical Parametric Mapping.
might be more pronounced in white matter regions of the
aging brain. Neuroinflammation has been directly implicated
in cognitive decline (Ownby, 2010). White matter tracts in
the brain are important for learning- (Hill, 2013; Fields,
2015) and information-processing (Fields, 2008). Neuroimaging
studies revealed that age-related white matter alterations underlie
cognitive decline (Bendlin et al., 2010). Considering the above-
mentioned factors, a detailed regional characterization of
microglia-induced neuroinflammation could provide insights
into the initiation of neurodegeneration.
Here, we analyzed the nature of microglial activity through
both the course of healthy aging and AD-related pathology to
investigate whether microglial activity shows a regional difference
between white matter and gray matter. Both human and
mouse tissues were studied. Gene expression analysis revealed
involvement of microglia in the pro-inflammatory response,
phagocytosis, and lipid homeostasis related to brain aging.
Morphological changes in microglia and phagocytosis marker
expression were most prominent in white matter regions of the
aging mouse brain. Using postmortem human brain samples as
well as non-invasive PET analysis, we were able to demonstrate
that the inflammatory activation of microglia starts in the white
matter regions already in middle-aged subjects. Finally, the
analysis of neuroinflammation in human EOAD and LOAD
samples showed prominently increased microglial activity in
white matter regions of EOAD brains, compared to young
controls. These data provide evidence that increased microglia-
induced neuroinflammation is predominant in the white matter
of aging- and AD brains. It is tempting to speculate that
neuroinflammation in the white matter may be used as an early
marker for the prediction of cognitive decline during aging.
MATERIALS AND METHODS
Animals
Young (2 and 4 months), middle age (13 months), and aged
(24 and 27 months) male C57BL/6 and DBA/2J mice were
purchased from Envigo. The animals were group-housed under
standard conditions (a 12 h light-dark alternating cycle, constant
temperature and humidity) and standard chow diet ad libitum
(ab diets; Cat. No. 2103). All animal experiments were carried out
in accordance with the European Directive (2010/63/EU) on the
protection of animals used for experimental and other scientific
purposes (Kilkenny et al., 2010). The protocols were approved
by the Animal Experimentation Committee of the University
Medical Center Groningen.
Acute Isolation of Microglia from Adult
Mouse Brain
Animals were sacrificed by means of saline perfusion under
inhalation anesthesia with 4% isoflurane in oxygen. The brains
were isolated and kept in ice-cold dissection solution (medium A:
HBSS containing 0.6% glucose and 15 mM HEPES buffer, Gibco).
For the isolation of microglia from white and gray matter regions,
the forebrain and cerebellum were cut into approximately
1.5 mm thick coronal sections. Dissection was performed under
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magnifying glass with the tissue wet with medium A. Corpus
callosum, cerebellar white matter were pooled from 2 to 3
animals of a particular age group and considered as one sample
from that age group. From the collected tissue, microglia were
isolated at high purity (>98%) using a discontinuous Percoll
gradient (Vainchtein et al., 2014). All steps of the isolation and
staining procedure were performed at 4◦C. Briefly, the tissue
was transferred to a tissue homogenizer (glass potter, Braun
Melsungen, Germany), and mechanically dissociated. The brain
homogenate was then filtered through a 70 µm cell strainer,
washed with medium A, and pelleted by centrifugation (220 × g,
10 min, arc 9, brake 9, 4◦C). The density gradient separation
was done using Percoll solutions with different densities (GE
Healthcare, 17-0891). To obtain a stock isotonic Percoll solution
(100%, density 1.123 g/ml), nine volume parts of Percoll (density
1.13 g/ml) were mixed with one volume part of 10x HBSS. Percoll
solutions with the appropriate concentration were prepared via
dilution of 100% Percoll with 1x PBS.
For the phagocytosis assay (n= 4) and FACS analysis (n= 5),
the cell pellet was resuspended in 75% Percoll (10 ml), overlaid
with 25% Percoll (10 ml), and PBS (6 ml) was added as the
final layer. Density separation was achieved by centrifugating the
discontinuous Percoll gradient in a swinging bucket centrifuge
(800 × g without brake for 25 min). After centrifugation, cells
were collected from the 75–25% Percoll interface, washed with
PBS, and pelleted by centrifugation (220 × g, 3 min, arc 9,
brake 9, 4◦C). The cell pellet was resuspended in culture medium
containing DMEM without phenol red, and containing 5% FCS,
1% penicillin/streptomycin, and 1% sodium pyruvate for the
phagocytosis assay. In case of flow cytometric analysis of surface
expression markers, the pellet was resuspended in medium A
which was prepared with HBSS devoid of phenol red. Subsequent
sample preparation steps are described in the flow cytometry
section.
For RNA used for microarray and quantitative real-
time polymerase chain reaction (qPCR), the cell pellet was
resuspended in 22% Percoll, and centrifuged for 20 min at
950 × g. The pellet was resuspended in HBSS buffer, and
incubated with CD11b-BV421 (Biolegend, 101236) and CD45-
FITC (eBioscience, 11-0451-85). The CD11bhi/CD45int/DAPIneg
population was isolated using FACS (FACSAria III cell sorter,
BD Biosciences). The collected populations were lysed in RLT
lysis buffer in subsequent steps for preparing the microarray and
qPCR.
Flow Cytometry
Cells resuspended in medium A (without phenol red) were
treated with 1% anti-CD16/32 (eBiosciences, 14-0161) for 15 min
to block Fc receptors and subsequently stained for different
surface markers (see below) for 20 min, washed with PBS,
pelleted by centrifugation, and resuspended in 200 µl of medium
A for subsequent flow cytometry analysis. During the staining
procedure, cells were kept on ice. The surface expression of
markers was measured with an FACSCaliburTM flow cytometer
(Becton Dickinson), and the flow cytometric measurements
were analyzed using FlowJo software R©. A small sample of the
cell suspension was stained for CD11b and CD45, and the
nuclear stain 4′,6-diamidino-2-phenylindole (DAPI, Biostatus),
to demonstrate the vital microglia (CD11bhi/CD45int/DAPIneg),
and to determine the purity of the preparation. The antibodies
used for immunophenotyping of mouse microglia are listed in
Table 3. For each staining, the appropriate isotype control was
used in a concentration-matched manner.
RNA Amplification, Microarray, and
Analysis
Microglia (n = 8) were sorted as a CD11bhi/CD45int/DAPIneg
population in RNA lysis buffer, and RNA was extracted using the
Qiagen RNeasy micro kit (Qiagen, 74004). RNA concentration
and integrity were measured on the Experion RNA HighSens
chip (Bio-Rad). Additional RNA amplification was performed
with the Nugen Ovation RNA amplification kit. Subsequently,
RNA was labeled and hybridized onto the Illumina mouseref-
8 V2.0 expression beadchip containing 25,600 probes, coding
for 19,100 genes. Genomestudio (version 1.9.0) was used to
generate expression values. Raw data were preprocessed and
analyzed using project R (version 2.13.1) and BioConductor
package Limma (version 1.8.18). Background correction was
done using infrared negative probes, and subsequently, quantile
normalization and log2 transformation were applied. Probes were
filtered out below a detection level of p< 0.05 in all samples as “no
expression” cases. A linear model approach was used to perform
differential gene expression analysis (with a FDR of p < 0.05 as
the cut-off value for significance). For further GO and pathway
analysis, DAVID (Database for Annotation, Visualization, and
Integrated Discovery) were used. Heatmaps were generated using
the heatmap.2 function of Bioconductor Package gplots.
qPCR Experiments
For microarray validation, RNA from sorted microglia (n = 4)
was extracted using the Qiagen RNeasy micro kit (Qiagen,
74004). Reverse transcription of the RNA was performed on
a MiniTM Thermal cycler (Bio-Rad) with a reaction mixture
containing RevertAidTM M-MuLV Reverse Transcriptase,
RibolockTM RNase Inhibitor, and M-MLV buffer (all Fermentas).
The RT-qPCR reaction, which contained iQTM SYBR R© Green
Supermix (Bio-Rad, 170-8882), was performed in 384-well plates
(Applied Biosystems) in an ABI7900HT Real-time PCR system
(Applied Biosystems). All primers from Biolegio, were designed
using NCBI Primer BLAST software. Table 4 details the primers
used. The other qPCR experiments were also performed in the
same method using at least two housekeeping genes HMBS,
HPRT in each experiment.
Phagocytosis Assay
Isolated cell pellets were resuspended in culture medium,
and seeded in an 8-well Lab-TekTM II Chambered Coverglass
(Thermo Fisher Scientific, 155409) at the density of 5,000 cells
per well. Cells were attached to the culture dish. Two hours
after seeding, the medium was replaced with culture medium
containing 25 µg/ml of pHrodoTM E. coli BioParticles R© conjugate
(Thermo Fisher Scientific, P35366). The cells were subsequently
imaged for 18 h with a Solamere Nipkow Spinning Disc Confocal
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laser scanning microscope. The microscope was mounted on a
Leica DM IRE2 inverted microscope which was equipped with a
Stanford Photonics XR/Mega-10I (intensified) CCD camera and
an ASI MS2000 Piezo motorized stage (37◦C, 5% CO2). The
pHrodo dye was excited with the 568 nm laser line of a dynamic
Krypton laser. For image acquisition, a 10× dry objective was
used. The fluorescence emission maximum of pHrodo is 585 nm.
A bright field and a red channel image (pHrodo emission) were
acquired every 5 min at each condition. Multiple cells were
selected as ROIs based on the bright field images. The intensity
of the ROIs in the red channel images was measured in each
frame of the entire image stack using an ImageJ plugin (written
by K. Sjollema; Microscopy Centre, University Medical Center
Groningen, University of Groningen). The data were plotted as
a time versus intensity curve, on which the time to reach half
maximum response for each cell was determined.
Immunohistochemistry for Animal Brain
Tissues
Animals (n = 3) were anesthetized and were perfused
transcardially for 20 min with 0.1M phosphate buffer (40–60 ml;
pH 7.4). Brains were removed and cut into two sagittal parts.
The right hemisphere was snap-frozen in liquid nitrogen. The
left hemisphere was immersed in 4% PFA overnight at 4◦C, then
transferred to 25% sucrose in PBS for 1 day, and finally frozen at
−50◦C.
Brain sections (60 µm free-floating cryostat sections) from
PFA-fixed samples were used for detecting IBA1 or Mac-2.
Sections were incubated for 10 min in 2% H2O2 in 70%
methanol, followed by blocking solution containing 5% normal
goat serum or fetal calf serum in phosphate buffered saline
(PBS) containing 0.1% Triton-X (Sigma, X-100) (denoted as
PBS+) for 30 min at room temperature. Subsequently, sections
were incubated overnight at 4◦C with rabbit anti-IBA1 (1:1000;
WAKO, 019-19741) or rat anti-Mac-2 (1:1000, Cedarlane,
CL8942AP) (detailed information in Table 5). As negative
controls, sections were incubated in buffer lacking the primary
antibody. After washed with PBS+, sections were incubated at
room temperature for 1.5 h with biotinylated goat anti-rabbit
(1:200; Vector Laboratories, BA-1000) or biotinylated rabbit anti-
rat (1:200; Vector Laboratories, BA-4000). Sections were then
rinsed in PBS+, and incubated with streptavidin-horseradish
peroxidase in accordance to the manufacturer’s instructions
(PK-6100; Vector Laboratories). The peroxidase reaction was
visualized by incubating the sections in PBS containing 0.5 mg/ml
3,3’-diaminobenzidine (DAB, Sigma, D-5637), and 0.33 µl/ml
H2O2. Then free-floating sections were subsequently mounted
on glass slides, dehydrated, and mounted with DePeX (Merck,
130-12-2). Alternatively, to differentiate between white and gray
matter tissues, some sections were stained with Luxol Fast
Blue (LFB) after the DAB reaction. Sections were subsequently
mounted on glass slides and dehydrated in an ascending ethanol
series (up to 96% ethanol), incubated in LFB working solution
[prepared by dissolving 0.5 g of Solvent Blue 38 (Sigma, 229342)
in 500 ml 96% ethanol including 10% acetic acid (Merck, 10063)]
at 60◦C overnight, and washed with 96% ethanol and distilled
water. Differentiation was achieved in 0.125% lithium carbonate
solution. The sections were rinsed in 70% ethanol followed by
distilled water. After dehydration, the sections were mounted
in DePeX. Slides were scanned using a ScanScope XT Digital
Slide Scanner (Aperio) at a resolution of 0.25 mm/pixel (100,000
pix/in) and data was analyzed with image processing in Fiji. First
we employed a color deconvolution method to separate stains
of cresyl violet and LFB from DAB immunostaining, so that
quantification of individual stains avoided cross contamination.
The deconvoluted images were color-thresholded to mark the
immunostained region within the image and positive pixels
quantified on a particle analysis plugin. For cerebellum sample,
white/gray matter could be hand drawn using free form regions
and pixels quantified within these regions and normalized for
area covered. A minimum of four brains were analyzed for each
age.
Brain sections (10 µm) from snap-frozen samples were used
for immunohistochemical analysis using the following primary
antibodies: Axl, Dectin1, Trem2, CD36, CD16/32, and CD11c
(detailed information in Table 5). Sections were fixed with
acetone for 10 min and then air-dried. Endogenous peroxidase
was inactivated by a 30-min incubation with peroxidase blocking
reagent from the DAKO envision kit (DAKO, K4009). Sections
were incubated for 30 min in 5% serum blocking, and then
for 2 h in the primary antibody at room temperature, followed
by rinsing with PBS. For those primary antibodies which
were not raised in rabbit, sections were incubated with the
secondary antibody which was raised in rabbit for another hour.
Afterward sections were incubated with labeled polymer-HRP
anti-rabbit (DAKO, K4009) at room temperature for 30 min. The
complex was visualized after 10 min incubation with 3-amino-
9-ethylcarbazole (AEC) substrate-chromogen solution (DAKO,
K4009), and counterstained with Mayer’s hematoxylin (Merck,
104302). Sections were finally covered with glycerol jelly.
Postmortem Human Brain Tissues
Postmortem human brain samples used for studying the aging
effect were obtained from the Department of Pathology, VU
University (Amsterdam). The rapid autopsy regimen of the
Netherlands Brain Bank in Amsterdam (coordinator Dr. I
Huitinga) was used to acquire subcortical white matter samples
from 15 control donors without any known neurodegenerative
condition (details in Table 1), with the approval of the medical
ethical committee of the VU University Medical Center, and
specific approval for the present study. All patients and control
donors had given informed consent for autopsy and the use of
brain tissue for research purposes.
Postmortem human brain samples used for investigating the
effect of AD pathology were obtained from Pathology division
of the Department of Pathology and Medical Biology, University
Medical Center Groningen (Groningen) and the Biobank of
the Institute Born-Bunge, University of Antwerp (Antwerp).
Paraffin-embedded samples were classified according to Braak
staging and age: (1) LOAD group: NFT stage = V or VI,
age > 60 years, n = 4; (2) Old control group: old clinically silent
cases, NFT stage= I, age> 60 years, n= 3; (3) EOAD group: NFT
stage = V or VI, age ≤ 60 years, n = 5; (4) Young control group:
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TABLE 1 | Patient data.
Case Age (years) Category in experiment Disease/cause of death
1 30–35 Young Subarachnoid bleeding
2 30–35 Young Familial cardiac problems (No pathology in the brain)
3 25–30 Young Arrhythmia (No pathology in the brain)
4 50–55 Middle-aged Cardiac arrest (No pathology in the brain)
5 50–55 Middle-aged Myocardial infarction, in brain minor hypertension related pathology
6 50–55 Middle-aged Myocardial infarction
7 50–55 Middle-aged Suicide
8 50–55 Middle-aged Esophageal cancer/euthanasia
9 56–60 Middle-aged Unknown
10 70–75 Aged Gastrointestinal bleeding, no pathology in brain
11 70–75 Aged Respiratory insufficiency due to bronchitis, in brain minor hypertension related pathology
12 70–75 Aged CREST syndrome, in brain small lacunar infarcts in thalamus
13 85–90 Aged Rectum and prostate cancer, cachexia and dehydration
14 80–85 Aged Pleuritis carcinomatosis
15 85–90 Aged Pneumonia and heart failure
young normal and clinically silent AD cases, NFT stage = 0 or I,
age ≤ 60 years, n= 13 (details in Table 2). All donors have given
written informed consent for autopsy and use of their brain tissue
for research purposes. The use of samples from young and old
controls and LOAD donors (details in Table 2) were approved by
the medical committee of University Medical Center Groningen.
The use of samples from 5 EOAD donors (details in Table 2)
were approved by ziekenhuis network Antwerpen (ZNA) ethics
committee.
Brain samples from patients who died of acute inflammatory
diseases (e.g., sepsis, pancreatitis) were used as positive controls
for detecting neuroinflammation. Seven brain samples were
obtained from the Pathology division of the Department of
Pathology and Medical Biology, University Medical Center
Groningen (details in Table 2). All donors had given written
informed consent for autopsy and use of their brain tissue for
research purposes. The use of samples were approved by the
medical committee of University Medical Center Groningen.
Immunohistochemistry for Human Brain
Tissues
Paraffin-embedded tissue (5 µm) of human brains from AD
and control groups were immunostained with IBA1 (1:1000,
WAKO, 019-19741), CD68 (1:50, DAKO, M0876) and HLA-DR
(1:100, eBioscience, 14-9956-82). Paraffin-embedded tissues from
different age groups were immunostained with CD68 (1:100,
DAKO, M0814) and HLA-DR (1:100, eBioscience, 14-9956-
82). Sections were deparaffinized with xylene and rehydrated
gradually from 100% ethanol to demi water. For antigen retrieval,
the sections were placed in 10 mM sodium citrate buffer (pH 6.0)
in a microwave for 12 min.
After rinsing in PBS, sections were pre-incubated in 3%
H2O2 for 30 min and then blocked with 10% normal horse
serum in PBS with 0.3% Triton-X100 for 30 min. Sections
were incubated overnight at 4◦C with abovementioned primary
antibodies in PBS with 0.3% Triton-X100 and 1% normal
horse serum. Sections were incubated with horse anti-mouse
biotinylated antibody (1:400, Vector Laboratories, BA2001) for
1 h at room temperature, incubated in avidin-biotin-peroxidase
complex for 30 min, and then visualized with DAB. Sections were
counterstained with Cresyl Violet and mounted with DePeX.
Slides were scanned using a digital slide scanner
(Hamamatsu), and data were analyzed with the positive
pixel count algorithm (Imagescope). For each human sample,
5–10 pictures per brain region (20× magnification) were
quantified. Transentorhinal region is the first region where the
AD pathology evolves (Braak stage I), whereas frontal cortex
(FC) is involved in the late stage of AD (Braak stage V) (Braak
et al., 2006). To investigate the regional differences in AD and
control groups, the positive pixels in the white matter below the
transentorhinal cortex (EC) and in the FC were quantified. For
samples from different age groups, the cortex and cerebellum
were quantified. The pictures of the stained sections were
separated by using color deconvolution method (Image J), and
the DAB-positive pixels were quantified.
Human Non-invasive PET Study for
[11C]-(R)-PK11195 Binding
Seven young (25.1 ± 2.9 years) and seven middle-aged
(55.7 ± 11.2 years) healthy subjects were included in the
study. Exclusion criteria were the presence of inflammation as
measured by CRP (i.e., CRP < 0.5 mg/L), concomitant or past
severe medical conditions, substance abuse, use of non-steroidal
anti-inflammatory drugs or paracetamol, and pregnancy. The
study was approved by the Medical Ethical Committee of the
University Medical Center Groningen. All subjects provided
written informed consent after receiving a complete description
of the study. All subjects had a structural T1-weighted MRI scan
of the brain (1.5 or 3 T) within 2 weeks of the PET procedure. The
MRI was used for anatomical reference and the delineation of the
ROIs.
[11C]-PK11195 PET images were acquired using an ECAT
EXACT HR+ camera (Siemens/CTI, Knoxville, TN, United
States). A 60-min dynamic scan in 3D-mode was performed,
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TABLE 2 | Patient data.
Sample ID Age (years) Braak stage Category in experiment Disease/cause of death
16 40–45 I Young control Arrhythmia
17 46–50 I Young control Cardiac death
18 46–50 I Young control Lymphoma
19 20–25 0 Young control Cardiac death
20 30–35 I Young control Myocardial infarction
21 20–25 I Young control Pulmonary embolism
22 40–45 I Young control Septicemia (acute inflammation)
23 36–40 I Young control Cardiac death
24 36–40 I Young control Cardiac death
25 40–45 I Young control Drug poisoning
26 4–45 0 Young control Cardiac death
27 20–25 0 Young control Ulcerative colitis
28 40–45 I Young control Pancreatitis (acute inflammation)
29 36–40 I Young control Pneumothorax
30 30–35 I Young control Drug overdose
31 30–35 VI EOAD Familial AD (neuropathologically confirmed)
32 40–45 VI EOAD Familial AD (neuropathologically confirmed)
33 56–60 V–VI EOAD AD, mutation PSEN 1 gene
34 56–60 V–VI EOAD AD
35 56–60 V–VI EOAD AD
36 66–70 I Old control Sepsis, pericarditis (acute inflammation)
37 60–65 I Old control Pneumonia (acute inflammation)
38 80–85 I Old control Myocardial infarction
39 76–80 I Old control Pancreas carcinoma
40 76–80 I Old control Respiratory insufficiency
41 80–85 V LOAD Cardiac death, leg infection (acute inflammation)
42 60–65 VI LOAD Bronchopneumonia (acute inflammation)
43 76–80 V LOAD Cachexia
44 70–75 V LOAD Aortic rupture
45 70–75 VI LOAD Pancreas carcinoma
46 76–80 V LOAD Pneumonia (acute inflammation)
47 70–75 V LOAD n.k
TABLE 3 | Antibodies for flow cytometry.
Antigen Species reactivity Host species Vendor Catalog number Isotype Conjugate
CD11b Mouse Rat eBioscience 12-0112 Rt IgG2b PE
CD45 Mouse Rat eBioscience 11-0451 Rt IgG2b FITC
F4/80 Mouse Rat Biolegend 123107 Rt IgG2a FITC
CD14 Mouse Rat eBioscience 11-0141 Rt IgG2a FITC
Tlr1 Mouse Rat eBioscience 12-9011 Rt IgG2a PE
Tlr4 Mouse Rat eBioscience 12-9041 Ms IgG1 PE
CD80 Mouse Hamster eBioscience 12-0801 Hm IgG PE
CD83 Mouse Rat eBioscience 11-0831 Rt IgG1 FITC
MHC II Mouse Rat eBioscience 11-5321 Rt IgG2b FITC
CD36 Mouse Rat eBioscience 12-0361 Rt IgG2a PE
CD88 Mouse Rat Biolegend 135805 Rt IgG2b PE
Isotype Mouse Rat Biolegend 407105 Rt IgG2a FITC
Isotype Mouse Rat Biolegend 400607 Rt IgG2b PE
Isotype Mouse Rat eBioscience 11-4210 Rt IgG2a FITC
Isotype Mouse Rat eBioscience 11-4220 Rt IgG2b FITC
Isotype Mouse Rat eBioscience 12-4015 Ms IgG1 PE
Isotype Mouse Hamster eBioscience 11-4888 Hm IgG PE
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TABLE 4 | Primer information.
Gene Accession number Forward sequence Reverse sequence Amplicon
Itgax NM-020008 CCCAACTCGTTTCAAGTCAG AGACCTCTGATCCATGAATCC 81 bp
LgalS3 NM-010705 CAGGATTGTTCTAGATTTCAGGAG TGTTGTTCTCATTGAAGCGG 73 bp
Axl NM-001190974 TGAAGCCACCTTGAACAGTC GCCAAATTCTCCTTCTCCCA 117 bp
CD36 NM-001159558 GATGTGGAACCCATAACTGGA AGGTACAATGTAAGGTCTCTTCAG 122 bp
Apoe NM-009696 TGTGGGCCGTGCTGTTGGTC GCCTGCTCCCAGGGTTGGTTG 106 bp
TABLE 5 | Antibodies for Immunohistochemistry.
Antigen Species reactivity Host species Vendor Catalog number Concentration
IBA1 Mouse/Human Rabbit Wako 019-19741 1:1000
Mac-2 Mouse Rat Cedarlane CL8942AP 1:1000
Axl Mouse Goat Santa Cruz SC-1096 1:100
Dectin1 Mouse Rat AbD Serotec MCA2289 1:100
CD36 Mouse Rat eBioscience 14-0361 1:100
CD16/CD32 Mouse Rat eBioscience 14-0161 1:100
CD11c Mouse Hamster eBioscience 14-0114 1:100
Trem2 Mouse/Human Rat R&D systems MAB17291 1:100
CD68 Human Mouse Dako IR613 1:50
HLA-DR Human Mouse eBioscience 14-9956-80 1:250
which consists of 21 successive frames of increasing duration
(6x 10, 2x 30, 3x 60, 2x 120, 2x 180, 3x 300, and 3x
600 s). During the scan, arterial blood radioactivity was
continuously monitored with an automated sampling system,
and additional manual arterial samples were taken for radio-
metabolite analysis. Detailed scanning and sampling procedures
were published previously (Doorduin et al., 2009). Head
movement was minimized with a head-restraining adhesive
band, and a neuroshield was used to minimize the interference of
radiation from the subject’s body. The images were reconstructed
by filtered back projection, and attenuation correction was
performed with the separate ellipse algorithm. The PET and
MRI images were coregistered using Statistical Parametric
Mapping (SPM2) software, and the aligned MRI image was
normalized to the SPM2 MRI template. The normalization
was then applied to the PET images. ROIs were created
using the automated anatomical labeling template (Tzourio-
Mazoyer et al., 2002) or were manually drawn onto the MRI.
The ROIs include the FC, occipital cortex, parietal cortex,
temporal cortex, cerebellum, hippocampus, thalamus, basal
ganglia, mesencephalon, pons, and corpus callosum. The time-
activity curves of all ROIs were used for kinetic modeling
using software developed in Matlab 7.1 (Mathworks, Natick,
MA, United States). Two-tissue compartment modeling was
used to calculate the K1–K4 according to the curve of whole
blood and metabolite-corrected plasma. The primary outcome
measure was the BPP, defined as k3/k4. Statistical analysis
was performed in PASW Statistics 18. One-way ANOVA was
used to determine differences in BPP between young and
middle-aged subjects. The correlation between age and the
BPP were assessed with Pearson’s product moment correlation
coefficient (r). Differences were considered statistically significant
when p < 0.05.
RESULTS
Microglia in the Aged Mouse Brain Are
Characterized by Increased
Phagocytosis and Altered Lipid
Homeostasis
To examine age-associated changes in gene expression, microglia
were isolated from aged mouse brain, and RNA expression was
determined. Microarray analysis of pure microglia showed> 1.5-
fold increased expression of 54 transcripts in aged mouse
microglia compared to young microglia. To relate the changes
in gene expression to a biological function, we applied DAVID
software and identified that differentially expressed genes were
involved in biological categories such as antigen processing and
-presentation, interferon signaling, regulation of macrophage
cytokine production, chemotaxis, cell adhesion, phagocytosis of
apoptotic cells, and lipid homeostasis.
Increased expression of genes in aged microglia, indicative
of a pro-inflammatory status, belonged to categories of antigen
presentation, interferon signaling, and cytokine signaling. These
groups were represented as a heatmap (Figure 1A), and included
several histocompatibility two genes (e.g., Egr1, Egr2, Stat1, and
Stat2) and phagocytic receptor genes (e.g., Axl, Clec7a, CD36,
Clec1a, Fcgr4, Clec3b, Clec4a1, Anxa3, Anxa4, and Anxa5).
Phagocytosis-associated genes were strongly upregulated in aged
microglia as validated by quantitative PCR of Axl, CD36, Ctse,
Clec7a, and Lamp2 (Figure 1B). In addition, aged microglia
showed changes in genes involved in cellular lipid homeostasis
(e.g., Apoe, Csf1, and Lpl). The altered genes are depicted in a heat
map (Figure 1A).
Despite their increased mRNA levels, the protein expression
levels of pattern recognition receptors (e.g., CD14, Tlr1, Tlr4)
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FIGURE 1 | Gene expression change and increased phagocytic capacity in aged microglia, compared to young microglia. (A) Heatmap of pro-inflammatory genes in
aged microglia vs. young mouse microglia. Functional annotation reveals genes upregulated in aged microglia to be involved in antigen processing and presentation
(red cluster), interferon signaling (light blue cluster) and cytokine signaling (dark blue cluster) (n = 8); Heatmap of genes involved in phagocytosis (orange cluster) and
lipid homeostasis (green cluster) in aged microglia vs. young microglia (n = 8); (B) Quantitative PCR validation of phagocytic genes in sorted microglia from young
(white bars) and aged (black bars) mouse brain (n = 4 young; n = 6 old); HMBS was used as the housekeeping gene. Asterisks ∗ indicate comparisons, for which
P-value was values indicated according to Student’s t-test, ∗∗P < 0.005, ∗∗∗P < 0.0005, ns, not significant. Error bars indicate standard deviation (SD). (C) After
purification, gated cells are CD11b high, CD45 intermediate, and F4/80 positive microglia. Antigen presenting molecules, CD14, Tlr4, Tlr1, CD80, CD83, and MHC II,
are not higher expressed at the protein level in aged microglia (n = 5); (D) Increased autofluorescence of aged microglia; (E) Lipid-related scavenger receptor CD36
and complement receptor CD88 are found to be upregulated in aged microglia (red) compared to young microglia (green) and higher than the corresponding isotype
controls and autofluorescence values (derived from unstained cells) (n = 5); (F) The phagocytic capacity of acutely isolated microglia was investigated by means of
live cell imaging using pHrodo coupled to bacterial particles (n = 4); (G) Quantification of the time to reach half maxima during phagocytic response of acutely
isolated microglia from young and aged mouse brains. The aged microglia need less time to reach the half maxima. Each depicted experiment is representative of
four independent experiments that yielded similar results. Student’s t-test ∗∗P < 0.005, Error bars indicate standard deviation.
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and proteins required for antigen presentation (e.g., MHC II,
CD80, and CD83) in aged microglia were not upregulated
compared to young microglia as shown in Figure 1C. Acutely
isolated microglia from aged mice display high autofluorescence
levels compared to young microglia as shown by flow cytometry
(Figure 1D). This could be due to the presence of lipofuscin.
Aged microglia also upregulate the expression of lipid-related
phagocytic receptor CD36 and complement receptor CD88 at the
protein level (Figure 1E).
To study their phagocytic activity, acutely isolated microglia
from young and aged mouse brains were incubated with
pHrodo-coupled Escherichia coli (E. coli) bacterial particles.
pHrodo is a pH sensitive dye which fluoresces only at acidic
pH, as found in late endocytic vesicles. This allows live cell
imaging of phagocytic uptake. Aged microglia phagocytose E. coli
bioparticles faster than young microglia. This is likely mediated
by increased expression of phagocytic receptors (Figure 1F).
Quantification shows that aged microglia reach half-maximal
levels of phagocytosis several minutes earlier than young
microglia (Figure 1G).
Increased Microglial Activity in the White
Matter Tracts of the Aged Mouse Brain
To investigate the effect of aging on the microglia phenotype,
age-related changes in microglia morphology were visualized
by staining with IBA1. During aging, IBA1 immunoreactivity
particularly increased particularly in white matter regions, such
as corpus callosum (2, 13, 24, and 27 months; Supplementary
Figure 1A). Morphological changes were also visible in gray
matter regions of the brain at 27 months (Supplementary
Figure 1A). Microglia cell clusters and changes in microglia
morphology were clearly observed at 24 months, particularly in
white matter areas like corpus callosum, anterior commissure,
dorsal fornix, and cerebellar white matter, compared to 4-month-
old mice (Figure 2A). In addition to white matter-enriched
regions, the cortex, hippocampus (Figure 2A), hypothalamus,
and spinal cord gray matter regions (data not shown) also showed
changes in microglia morphology in aged (24 months) mouse
brain. Microglia cell clusters (Supplementary Figure 1B) and
the presence of beaded structures in processes of IBA1-positive
microglia (Supplementary Figure 1B) were exclusively found in
the aged (24 months) mouse brain.
Mac-2, also known as LgalS3, expressed by phagocytic
subpopulations of microglia (Rotshenker, 2009), was selectively
detected in the white matter tracts of the aged brain, particularly
in the corpus callosum, anterior commissure, and the cerebellar
white matter (Figure 2B). Gray matter regions, such as cerebral
cortex did not express Mac-2 (LgalS3, Figure 2B). Quantification
of IBA1 (Figure 2C), Mac-2 (Figure 2D) immunoreactive pixels
showed significant differences in number of positive pixels,
particularly in white matter regions with aging. Similar patterns
of expression were also observed for Axl, CD36, CD16/32,
CD11c, Trem2, and Dectin1 (Clec7a) in the genu of corpus
callosum (Figure 3A). All these proteins were highly expressed in
the white matter of the aged brain. Microglia were isolated from
white or gray matter-enriched brain regions, and checked for
RNA expression of phagocytosis- and activation markers found
in weighted correlation network analysis (WGCNA) (Holtman
et al., 2015). Expression of Axl, CD36, Clec7a, LgalS3, and Apoe
were found to be significantly higher in the white matter of the
aged mice (Figure 3B).
Neuroinflammation in the Human Brain
Starts during Middle Age in White Matter
Regions
In order to investigate whether the observed differences in white-
and gray matter in terms of morphology and gene expression
in mice also occurred in humans, post-mortem human brain
tissues of young (27–33 years), middle-aged (51–56 years), and
aged (70–87 years) people were analyzed. The selected individuals
were devoid of neurological conditions or inflammatory diseases
around the period of death. Immunostaining for IBA1, CD45,
HLA-DR, and CD68 was performed. Microglia stained with
IBA1 and CD45 were found in white and gray matter (data
not shown). CD68, a protein associated with lysosomes, was
selectively detected in microglia in white matter regions including
corpus callosum, cerebellar white matter, and cortical white
matter (Supplementary Figures 2C,G,I compared to B,H; low
magnification overview in supplementary Figure 2A). HLA-DR,
a molecule involved in antigen presentation, was restricted to
white matter tracts within the same brain regions (Supplementary
Figures 2F,J,L compared to E,K; Low magnification overview
in Supplementary Figure 2D). The expression levels of CD68
and HLA-DR increased with age in cortical and cerebellar
white matter (Figure 4A). Quantification of immunostaining
showed an increase with age and regional microglia activation
(Figure 4B).
To further investigate if the regional differences in microglia
activation can be observed non-invasively we quantified the
extent of radioactive ligand [11C]-PK11195 binding using PET
imaging. It must be noted, however, that [11C]-PK11195 is also
known to bind reactive astrocytes and endothelium (Turkheimer
et al., 2015). The PET images displayed an axial plane of the
human brain, showing the binding of [11C]-PK11195 in the white
matter of young and middle-aged healthy volunteers. The images
(axial view) represent the average [11C]-PK11195 uptake in the
white matter of seven young (Figure 5A) and seven middle-
aged (Figure 5B) healthy volunteers 50–60 min post-injection.
The axial images clearly showed average [11C]-PK11195 uptake
increased in the white matter of the aged brain already during
middle age. Positive correlation was observed in [11C]-PK11195
binding in the corpus callosum upon aging (Figure 5C). The
binding of [11C]-PK11195, indicative of neuroinflammation,
was significantly higher in the corpus callosum of middle-aged
subjects than in young subjects (3.14 ± 0.51 vs. 2.31 ± 0.72;
p < 0.05) (Details in Table 6).
Comparison of Microglia Activation upon
Systemic Inflammation and LOAD
To evaluate the neuroinflammation status in aging and AD,
we first investigated brain sections from people who died of
acute inflammatory diseases, which were used as positive controls
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FIGURE 2 | Increased cellular clustering and IBA1 immunoreactivity in the white matter of the aging brain. (A) IBA1 staining coupled to Luxol fast blue staining in
young and aged brains. Comparison of the density of microglia in the cortex, hippocampus and white matter regions, such as corpus callosum (CC), anterior
commissure (AC), cerebellar white matter, and dorsal fornix; (B) Mac-2 staining together with luxol fast blue staining show increased Mac-2 positivity in the white
matter of aged compared to young brain. Increased Mac-2 positivity is observed in white matter tracts including corpus callosum, anterior commissure, and
cerebellar white matter; (C) Quantification of IBA1 positive pixels in different regions of young (n = 4) and old brains (n = 4). (D) Quantification of IBA1 positive pixels in
different regions of young (n = 4) and old brains (n = 4). Scale bar: (A,B) = 25 µm. For, (C,D) Student’s t-test ∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.0005, ns, not
significant. Error bars indicate standard deviation (SD).
for the further study. In addition, we compared a young non-
demented control group (Braak stage 0-I) and a group of LOAD
tissue samples (Braak stage V-VI). For each group, we compared
the expression of IBA1, HLA-DR, and CD68 between the patients
who died of acute inflammatory disease and those who died
without systemic inflammation (Supplementary Figure 3A). In
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FIGURE 3 | The change of microglial gene expression during aging mainly occurs in the white matter of mouse brain. (A) The increased expression of genes involved
in microglia phagocytosis and activation (Axl, CD36, CD16/32, CD11c, Trem2, and Dectin1) is found specifically in the white matter of aged brain (24 months, n = 3),
compared to young brain (4 months, n = 3); (B) Quantitative PCR evaluation of microglia phagocytic genes associated with aging (4 months, n = 4; 24 months,
n = 4). Increased expression of phagocytic markers (Axl, CD36, Clec7a, LgalS3, and Apoe) in microglia isolated from white matter enriched brain regions. GM, gray
matter; WM, white matter. HMBS was used as the housekeeping gene. ANOVA ∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.0005. Error bars indicate standard deviation (SD).
the non-demented group, white-matter microglia of samples with
acute infection showed deramified morphology (Supplementary
Figure 3A) and expressed significantly higher levels of IBA1
and CD68. However, the expression of HLA-DR did not change
significantly in the white matter between acute-inflammation-
and non-inflammation groups (Supplementary Figure 3B). In
the LOAD group, the expression of IBA1, HLA-DR, and
CD68 was not significantly different between inflammation-
and non-inflammation groups (Supplementary Figure 3B). In
conclusion, these data indicate that acute inflammation in
addition to neurodegeneration did not further alter microglial
morphology.
Increased Microglial Immunoreactivity in
the White Matter of Early-Onset AD
Brains
To investigate the effect of AD pathology on microglial
immunoreactivity in white matter in relation to age, we compared
the immunostaining between EOAD, LOAD, and age-matched
controls (Figure 6A). Patients with inflammatory diseases prior
to death were excluded. We investigated microglial activity in
the white matter of FC and entorhinal cortex. Interestingly,
white matter microglia in both regions of EOAD tissues showed
significantly increased expression of IBA1, HLA-DR, and CD68,
compared to age-matched controls (Figure 6B). To check the
effect of aging on microglia activity, we studied the white matter
of old controls, which showed upregulated expression of IBA1,
HLA-DR, and CD68, compared to young controls (Figure 6B).
To investigate the combined effect of aging and AD pathology
on white matter pathology, we further compared the expression
of IBA1, HLA-DR, and CD68 between LOAD and old controls.
Interestingly, there was no significant difference between these
two groups (Figure 6B). In summary, aging and AD-related
pathology may increase microglia activity separately, but the
combined effect is not additive. Aging- and AD-related microglial
activation are morphologically similar.
DISCUSSION
In this study, we investigated age- and AD-related
neuroinflammation in white matter tissue of both mice and
humans. Upon aging, microglia activation (an indicator
of neuroinflammation) was increased specifically in white
matter regions in both mice and humans. The presence of
activated microglia during aging in humans was also examined
using PET scanning. The findings reveal that white matter is
strongly affected both in aging and AD pathology. The regional
phenotypic change of microglia in white matter may be of
special relevance for the mechanism of brain aging. Whereas
cognitive dysfunction during aging has been proposed to be due
to neuronal loss, modern stereotactic approaches have shown
limited neuronal death in the aged brain (Burke and Barnes,
2006; Rock and Kono, 2008; Bishop et al., 2010). The white matter
tracts in the brain serve for functional connectivity and speed of
processing. Compromised white matter integrity during aging
can, therefore, affect cognition markedly (de Lange et al., 2016).
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FIGURE 4 | Age-associated immunoreactivity increases in CD68 and HLA-DR. (A) Immunostaining for CD68 and HLA-DR in young, middle aged, and aged human
brain. The regions are cortex and cerebellum. The boundary between white and gray matter regions is drawn in green. (B) Quantification of immunostaining for CD68
and HLA-DR shows clear differences in white matter compared to corresponding gray matter within the same brain region. Changes in white matter start in middle
aged samples (Young, n = 3; Middle aged, n = 6; Aged, n = 6). Scale bar: (A) = 200 µm, insert = 25 µm. Mann–Whitney’s test ∗P < 0.05, ∗∗P < 0.005,
∗∗∗P < 0.0005. Error bars indicate standard deviation (SD).
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FIGURE 5 | PET studies using [11C]-PK11195 to localize age-associated microglial activation in white matter. Axial image of the human brain showing white matter
[11C]-PK11195 average uptake in (A) young and (B) middle aged healthy volunteers (n = 7); (C) Positive correlation between [11C]-PK11195 binding potential (BPP)
in the total corpus callosum and age of subjects.
TABLE 6 | Binding potential of [11C]-PK11195 in different brain regions of young and mid-aged brains.
Brain region Young average Young SD Middle-aged average Middle-aged SD P-value
Amygdala 1.42 0.35 1.79 0.37 0.090
Basal ganglia 1.26 0.21 1.65 0.73 0.238
Cerebellum 0.92 0.19 1.47 1.06 0.242
Cingulum 1.21 0.32 1.52 0.59 0.278
Frontal cortex 1.55 0.65 1.82 1.13 0.591
Hippocampus 1.14 0.29 1.47 0.39 0.094
Insula 1.04 0.13 1.19 0.29 0.228
Occipital cortex 1.68 0.81 1.36 0.28 0.381
Parietal cortex 1.72 0.88 1.28 0.22 0.262
Temporal cortex 1.05 0.28 1.21 0.21 0.279
Thalamus 1.04 0.27 1.16 0.42 0.566
Mesencephalon 1.51 0.51 2.05 1.23 0.307
Pons 1.31 0.37 1.89 0.59 0.051
Corpus callosum_total 2.69 0.92 3.64 0.63 0.045
Corpus callosum_trunk 2.31 0.72 3.14 0.51 0.038
Corpus callosum_splenium 3.52 1.16 4.34 1.23 0.223
Corpus callosum_genu 2.79 1.03 4.42 1.99 0.078
White matter 1.73 0.60 1.79 0.40 0.829
Microglia as sentinels of the brain show early alterations in white
matter, and therefore draw attention to changes in the white
matter of the aging brain. In AD patients, the upregulation of
proinflammatory cytokines, chemokines, and other immune
mediators has been associated with neuropathology (Griffin
et al., 1989; Xia et al., 1998; Ojala et al., 2009). Interestingly, the
increased expression of immune factors may precede AD-like
pathology (Krstic et al., 2012). Our research, for the first time,
shows increased microglia-induced neuroinflammation in the
white matter of EOAD, compared to age-matched controls.
Interestingly, the microglia-induced neuroinflammation did not
increase in the white matter of LOAD compared to age-matched
controls.
We performed mRNA expression analysis of microglia
isolated from young and aged mouse brains. As expected
for aging brain tissue (Luo et al., 2010), the expression of pro-
inflammatory genes involved in antigen presentation, interferon-,
cytokine-, and chemokine signaling, and phagocytosis were
enhanced in aged microglia. This gene expression pattern
suggests that, during aging, the brain changes from a state
of homeostatic equilibrium to a proinflammatory state.
However, the activation of microglia is a graded process
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FIGURE 6 | White matter immunoreactivity in IBA1, HLA-DR and CD68 increases in early-onset AD, but not in late-onset AD. (A) Transentorhinal cortex (EC) and
frontal cortex (FC) sections of early-onset AD (Braak stage V-VI, n = 5), late-onset AD (Braak stage V-VI, n = 4) and their age-matched controls (Braak stage 0-I;
Young controls n = 13; Old controls n = 3) are immunostained for IBA1, HLA-DR, and CD68. (B) Quantification of positive pixels of IBA1, HLA-DR, and CD68
staining shows that the expression of IBA1, HLA-DR, and CD68 increases in early-onset AD, compared to age-matched controls. There is no significant differences
of IBA1, HLA-DR, or CD68 expression between the late-onset AD and age-matched controls. Scale bar: (A) = 40 µm. Mann–Whitney test, ∗P < 0.05, ∗∗P < 0.01,
Error bars indicate standard error.
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depending on the nature and extent of injury. The aging-related
phenotype of microglia correlates with enhanced sensitivity
for proinflammatory stimuli referred to as “immune primed”
(Perry et al., 2007). Our data shows that the upregulation of
pro-inflammatory transcripts is present at the RNA level, but not
at the protein level. This suggests that, while microglia are in a
“prepared” state at the RNA level, active translation or functional
consequence is not initiated in the absence of an additional
stimulus.
Several phagocytic receptors, including CD36, CD16/32, Axl,
Dectin 1, and Trem2 are upregulated in white matter microglia.
Scavenger receptor CD36 is involved in inflammatory responses
to many ligands [e.g., lipids, amyloid β, and bacteria (Silverstein
et al., 2010)]. Fc gamma receptors (i.e., CD16 and CD32) show
multiple functions in a number of cellular responses including
the release of inflammatory mediators, cytotoxic triggering, cell
activation, and the phagocytosis of antibody-coated particles
(Nagarajan et al., 1995). Axl is an inflammatory response
receptor involved in the clearance of apoptotic cells, and its
expression is induced by proinflammatory stimuli (Zagorska
et al., 2014). Dectin 1 is a pattern-recognition receptor which
can detect β-glucans in fungal cell walls (Goodridge et al., 2011).
Trem2-mediated signaling has been shown to be responsible
for regulating phagocytosis and lipid catabolism in vivo (Poliani
et al., 2015). A rare R47H mutation of TREM2 correlates with a
substantial increase in the risk of developing Alzheimer’s disease
(AD) possibly due to impaired detection of damage-associated
lipid patterns associated with neurodegeneration by microglia
(wang et al., 2015). In our study, acute isolation of microglia
from young and aged mouse brains shows that aged microglia
phagocytose at a faster rate than young microglia, although the
maximal amount of particles that can be phagocytosed by young
and aged microglia is similar. Interestingly, other studies have
convincingly shown that in aged microglia the phagocytosis of
amyloid-β is impaired (Floden and Combs, 2011; Njie et al.,
2012). Studies which investigated phagocytosis in vivo have
shown exciting new functions for microglia, and this approach
might reveal interesting insights for aging microglia as well
(Sierra et al., 2013).
In line with previous findings, we observed that in human
white matter, the activation of microglia was already detected
at middle age (Salat et al., 2005; Brickman et al., 2006). A large
gene expression study in the aging human brain also showed
upregulation of neuroinflammation-associated genes at middle
age (Lu et al., 2004). Interestingly, cognitive decline in humans
has been reported to begin as early as at the age of 45 years
(Singh-Manoux et al., 2012). PET imaging using the radioactive
ligand [11C]-PK11195 for translocator protein (TSPO) located on
the outer mitochondrial membrane of glial cells (Casellas et al.,
2002), has been used to study neuroinflammation in a variety
of conditions (Stephenson et al., 1995; Vowinckel et al., 1997;
Venneti et al., 2009). In the current study, we investigated young
and middle-aged subjects, but a systematic investigation in a
large extended cohort of aged human subjects above 75 years
old is required to fully assess whether we can effectively use
this method especially in conjunction with approaches such as
diffusion tensor imaging of white matter integrity to improve our
diagnostic potential for neurodegenerative conditions. Currently,
a proper correlation between the cognitive performance, and the
BPP in the white matter of middle-aged individuals is still lacking.
A longitudinal study with repeated measurements of cognitive
performance and BPP of [11C]-PK11195 in different regions of
the middle-aged control brain would be of interest in this matter.
Our study shows increased microglia-induced
neuroinflammation in the white matter of EOAD, compared to
young controls. Previous imaging studies showed white matter
atrophy and degeneration in EOAD patients in the genu, body,
and the splenium of corpus callosum, fornix, and main anterior-
posterior pathways (Migliaccio et al., 2012; Caso et al., 2015),
which is consistent with the white matter pathology observed
in our study using immunohistochemistry. Interestingly, in a
study using diffusion-tensor MR imaging subtle changes along
the white matter tracts in AD patients were detected (Caso et al.,
2015). This would mean that white matter abnormalities could
be an early marker that possibly precedes gray matter atrophy,
particularly in EOAD (Caso et al., 2015), as well as in healthy
aging. Previous studies in mild cognitive impairment patients
clearly indicated that white matter changes could be detected
even before the development of cortical atrophy (Agosta et al.,
2011; Maier-Hein et al., 2015). Detection of neuroinflammation
at an early stage might serve as a good predictor for the onset
of dementia and neurodegeneration in EOAD. Clearly, our
present study using immunohistochemistry to investigate the
post-mortem samples has limitations to answer whether the
occurrence of neuroinflammation in the white matter is indeed
the initiator of the cognitive decline in EOAD. To address this
question in future, it will be necessary to conduct a long-term
study (including neuroimaging and cognitive studies) on the
carriers of EOAD mutations at the preclinical stage.
In contrast to EOAD, the expression of IBA1, HLA-
DR, or CD68 in the white matter of LOAD brain is not
significantly higher than that in age-matched controls. The
different underlying mechanisms of EOAD and LOAD may
explain the difference in the contribution of the neuroimmune
system to AD pathology. Early-onset familial AD patients carry
mutations in three genes, which encode amyloid precursor
protein (APP), presenilin-1 (PS1), and PS2. These mutations
can change the APP metabolism profoundly, and lead to
overexpression and aggregation of Aβ. However, in LOAD,
recent genome-wide association studies have found risk genes
(e.g., TREM2, CD33) relating to microglia phagocytosis in the
innate immune system. The mutations of TREM2 and CD33 will
lead to reduced Aβ clearance and an increased inflammatory
response (Griciuc et al., 2013; Hickman and El Khoury, 2014).
The chronic inflammatory response may cause the dysregulation
of clearing misfolded neuronal proteins which accumulate during
aging (Krstic and Knuesel, 2013). The relationship between white
matter changes and cognitive functions in LOAD is a matter of
debate, and neuroimaging studies have shown conflicting results.
A few studies have reported a significant correlation (Diaz et al.,
1991; Stout et al., 1996), whereas others have failed to find any
relationship in AD (Leys et al., 1990; Brilliant et al., 1995; Hirono
et al., 2000). In our study, the non-significant change in the white
matter of LOAD and aging brains supports the latter notion
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that cognitive decline in LOAD is not associated with white
matter change.
Until now, the systematic evaluation of white matter
neuroinflammation in relation to aging and neurodegeneration
has received much less attention than gray matter
neuroinflammation. Postmortem AD brain samples analysis,
together with the information of premortem cognitive status
and the presence of neuritic plaques, has shown that microglia
activation is more prominent in white matter than in gray
matter at early clinical dementia stages (i.e., CDR score: 0, non-
demented; 0.5, questionable dementia) (Xiang et al., 2006). With
progressive increase in plaque pathology and the worsening
of clinical dementia symptoms, microglia activation becomes
comparable in both white- and gray matter (Xiang et al., 2006).
Here, we provide evidence of increased microglia-induced
neuroinflammation in the white matter of aging and AD brains.
With the fast development of neuroimaging techniques and novel
imaging-based, CSF-based biomarkers (Humpel, 2011; Varrone
and Nordberg, 2015; Zhang, 2015), the detection of microglia-
induced neuroinflammation in the white matter may identify
reliable markers to monitor disease onset, progression, and
therapeutic efficacy.
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